Another study reported that HSCs can mediate hepatoma progression by releasing factors that promote epithelial-mesenchymal trans-formation and angiogenesis, such as VEGF, MMP2, MMP9, bFGF, and TGF-β (27, 28). The gene discussed is FGF2; the disease is hepatocellular carcinoma.